These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Advantages with prophylactic PEG-rhG-CSF versus rhG-CSF in breast cancer patients receiving multiple cycles of myelosuppressive chemotherapy: an open-label, randomized, multicenter phase III study. Xie J, Cao J, Wang JF, Zhang BH, Zeng XH, Zheng H, Zhang Y, Cai L, Wu YD, Yao Q, Zhao XC, Mao WD, Jiang AM, Chen SS, Yang SE, Wang SS, Wang JH, Pan YY, Ren BY, Chen YJ, Ouyang LZ, Lei KJ, Gao JH, Huang WH, Huang Z, Shou T, He YL, Cheng J, Sun Y, Li WM, Cui SD, Wang X, Rao ZG, Ma H, Liu W, Wu XY, Shen WX, Cao FL, Xiao ZM, Wu B, Tian SY, Meng D, Shen P, Wang BY, Wang Z, Zhang J, Wang L, Hu XC. Breast Cancer Res Treat; 2018 Apr; 168(2):389-399. PubMed ID: 29230663 [Abstract] [Full Text] [Related]
29. Pegylated recombinant human granulocyte colony-stimulating factor regulates the immune status of patients with small cell lung cancer. Sun J, Bai H, Wang Z, Duan J, Li J, Guo R, Wang J. Thorac Cancer; 2020 Mar; 11(3):713-722. PubMed ID: 32020764 [Abstract] [Full Text] [Related]
30. Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma. Viens P, Gravis G, Bladou F, Lechevallier E, Baume D, Camerlo J, Cowen D, Coulange C, Serment G, Resbeut M, Maraninchi D. Eur Cytokine Netw; 1996 Sep; 7(3):395-9. PubMed ID: 8954183 [Abstract] [Full Text] [Related]
35. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, Yagoda A, Fain K, Moore MA, Clarkson B, Oettgen HF, Alton K, Welte K, Souza L. N Engl J Med; 1988 Jun 02; 318(22):1414-22. PubMed ID: 2452983 [Abstract] [Full Text] [Related]
37. Randomized study of dose or schedule modification of granulocyte colony-stimulating factor in platinum-based chemotherapy for elderly patients with lung cancer. Oshita F, Yamada K, Nomura I, Tanaka G, Ikehara M, Noda K. Oncol Rep; 2001 Jun 02; 8(4):861-6. PubMed ID: 11410799 [Abstract] [Full Text] [Related]